A preclinical evaluation of the MEK inhibitor refametinib in HER2-positive breast cancer cell lines including those with acquired resistance to trastuzumab or lapatinib
| Image |  |
|---|---|
| Description | scientific article published on 22 July 2017 |
| Author/s |
author: Bryan T. Hennessy Stephen F Madden Lance A. Liotta Sinead Toomey Joyce O'Shaughnessy Alex J. Eustace |
| Publication date | July 22, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |